drugset / Trial / NCT01866709
Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia
RandomizedParallel-groupTriple-blindSupportive care
Summary
It is hypothesized that SPS is more effective than placebo control (alternative hypothesis) in lowering i-STAT potassium levels in subjects with i-STAT potassium levels between 5.0 - 6.5 mmol/l versus no difference between SPS and placebo control (null hypothesis).
Timeline
- Start
- 2013-05
- Primary completion
- 2013-07
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | sodium polystyrene sulfonate | Other / unclassified | 15 g | Oral |
Indications
No indication recorded.